Co-existence of bla

K. pneumoniae carbapenemases whole-genome sequencing

Journal

Journal of global antimicrobial resistance
ISSN: 2213-7173
Titre abrégé: J Glob Antimicrob Resist
Pays: Netherlands
ID NLM: 101622459

Informations de publication

Date de publication:
24 Feb 2024
Historique:
received: 21 12 2023
revised: 05 02 2024
accepted: 17 02 2024
medline: 27 2 2024
pubmed: 27 2 2024
entrez: 26 2 2024
Statut: aheadofprint

Résumé

K. pneumoniae is a common cause of severe hospital-acquired infections. In the present study we have characterized the whole-genome of two K. pneumoniae ST437 belonging to the clonal complex CC258. The whole-genome sequencing was performed by MiSeq Illumina, with a 2×300bp paired-end run. ResFinder 4.4.2 was used to detect acquired antimicrobial resistance genes (ARGs) and chromosomal mutations. Mobile genetic elements (plasmids and ISs) were identified by MobileElementFinder v1.0.3. The genome was also assigned to ST using MLST 2.0.9. Virulence factors were detected using Virulence Factor Database (VFDB). K. pneumoniae KPNAQ_1/23 and KPNAQ_2/23 strains, isolated from urine samples of hospitalized patients, showed resistance to most antibiotics including ceftazidime-avibactam, ceftolozane-tazobactam and meropenem-vaborbactam combinations. Both strains were susceptible only to cefiderocol. Multiple mechanisms of resistance were identified. Resistance to β-lactams was due to the presence of NDM-5, OXA-232, CTX-M-15, SHV-182 β-lactamases and OmpK36 and OmpK37 porin mutations. Resistance to fluoroquinolones was mediated by chromosomal mutations in acrR, oqxAB efflux pumps and the bifunctional gene aac(6')-Ib-cr. The presence of different virulence genes makes these KPNAQ_1/23 and KPNAQ_2/23 as high-risk clones.

Identifiants

pubmed: 38408564
pii: S2213-7165(24)00042-0
doi: 10.1016/j.jgar.2024.02.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Auteurs

S Di Marcantonio (S)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

M Perilli (M)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

G Alloggia (G)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy; Medicine Laboratory, San Salvatore Hospital, L'Aquila, Italy.

B Segatore (B)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

G Miconi (G)

Medicine Laboratory, San Salvatore Hospital, L'Aquila, Italy.

G Bruno (G)

Medicine Laboratory, San Salvatore Hospital, L'Aquila, Italy.

P Frascaria (P)

Medicine Laboratory, San Salvatore Hospital, L'Aquila, Italy.

A Piccirilli (A)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy. Electronic address: alessandra.piccirilli@univaq.it.

Classifications MeSH